GERM vs. YYY
GERM (Amplify Treatments, Testing and Advancements ETF) and YYY (Amplify CEF High Income ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while YYY is a Diversified Portfolio fund tracking the Nasdaq CEF High Income™ Index. Both are passively managed. Over the past year, GERM returned 0.00% vs 11.21% for YYY. GERM charges 0.68%/yr vs 3.23%/yr for YYY.
Performance
GERM vs. YYY - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- 6M
- 0.00%
- YTD
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
YYY
- 1D
- -0.26%
- 1M
- 1.54%
- 6M
- 4.40%
- YTD
- 6.40%
- 1Y
- 11.21%
- 3Y*
- 12.25%
- 5Y*
- 3.71%
- 10Y*
- 5.47%
GERM vs. YYY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
YYY Amplify CEF High Income ETF | 6.40% | 13.08% | -0.87% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. YYY — Risk / Return Rank
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
YYY
GERM vs. YYY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify CEF High Income ETF (YYY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERM | YYY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.25 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 1.39 | — |
| Martin ratioReturn relative to average drawdown | — | 6.02 | — |
Loading charts...
Drawdowns
GERM vs. YYY - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum YYY drawdown of -42.52%. Use the drawdown chart below to compare losses from any high point for GERM and YYY.
Loading charts...
Drawdown Indicators
| GERM | YYY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -42.52% | +42.52% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -8.07% | +8.07% |
Max Drawdown (3Y)Largest decline over 3 years | — | -13.47% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -27.71% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -42.52% | — |
Current DrawdownCurrent decline from peak | 0.00% | -0.52% | +0.52% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -6.79% | +6.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 1.86% | -1.86% |
Volatility
GERM vs. YYY - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify CEF High Income ETF (YYY) has a volatility of 1.73%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than YYY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | YYY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 1.73% | -1.73% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 7.23% | -7.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 8.63% | -8.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 11.37% | -11.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 13.87% | -13.87% |
GERM vs. YYY - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is lower than YYY's 3.23% expense ratio.
Dividends
GERM vs. YYY - Dividend Comparison
GERM has not paid dividends to shareholders, while YYY's dividend yield for the trailing twelve months is around 12.52%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YYY Amplify CEF High Income ETF | 12.52% | 12.51% | 12.50% | 12.39% | 12.36% | 9.08% | 9.79% | 9.10% | 9.73% | 8.16% | 10.34% | 10.77% |
Frequently Asked Questions
YYY has higher volatility (1.73%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs YYY's -42.52%.
On 1-year performance, YYY leads with 11.21% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, YYY has performed better with a 11.21% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GERM is cheaper with a 0.68% expense ratio, compared with 3.23% for YYY.
YYY has the higher dividend yield at 12.52%, compared with 0.00% for GERM.
GERM is categorized as Health & Biotech Equities, while YYY is Diversified Portfolio. GERM tracks Prime Treatments, Testing and Advancements Index, while YYY tracks Nasdaq CEF High Income™ Index. Their fees differ too: 0.68% for GERM and 3.23% for YYY.
Find the right allocation for GERM and YYY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer